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Abstract
Background. Celiac disease (CD) is significantly underdiagnosed, despite significant efforts made in the last 
decades to increase its diagnostic rate. This has lead to a high need for developing new diagnostic strategies. Our 
aim was to evaluate the diagnostic performance of two routine hematologic indices for CD. 
Methods. In a prospective observational study, 34 newly diagnosed CD patients, 34 age-sex matched controls 
with irritable bowel syndrome (IBS) and 16 treated CD patients were assessed regarding the differences in mean 
lymphocyte count (LY), red blood cell distribution width (RDW) and their ratio (RDW/LY).  Results. Elevated 
RDW (>14) and lymphopenia (<1.5 x 10e9/L) were more frequently seen in newly diagnosed CD patients compared 
to IBS control group and treated CD patients. Newly diagnosed CD patients had significantly higher mean values of 
RDW/LY - 10.09, compared to 7.72 in the CD-treated group and 6.79 in IBS controls (p<0.01). Subgroup analysis 
revealed that RDW/LY was higher in patients with destructive histology (Marsh≥3a), 10.54 vs. 7.99. For a value 
over 7, RDW/LY had a sensitivity of 88.24% (95% CI 72.55-96.70%) and AUROC of 0.785 (95% CI 0.683- 0.887). 
Conclusions. RDW/LY ratio is a widely available tool which could be used routinely in clinical practice for 
CD screening. .
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Introduction
Despite significant efforts made in the last 
decades by increasing awareness among both 
medical professionals and non-professionals, 
improving availability of serological testing, de-
velopment of point-of-care tests and case-find-
ing strategies (1), celiac disease (CD) remains 
heavily underdiagnosed (2). Undiagnosed CD is 
associated with risk of complications and poor 
quality of life which could be avoided by glu-
ten-free diet (3,4).  
In this setting, a need for developing new 
diagnostic strategies emerged, and attention has 
been pointed towards the routine workup of pa-
tients, aiming at maximizing selection of those 
with likelihood of CD. This would allow greater 
number of patients to be correctly selected for 
further specific testing. Hematologic changes 
are common in CD patients (5,6), but they are 
not frequently reported in current guidelines 
(3,7,8). These changes in routine laboratory 
workup results can be subtle, but at the same 
time they can be the only sign of disease in some 
of the patients.
Among these hematologic indices, red 
blood cell distribution width (RDW) has been 
previously reported as a sensitive marker for 
CD (9,10), and its diagnostic performance as a 
screening test is improved in association with 
other markers (11). Low lymphocyte counts 
have also been described in association with ce-
liac disease (12,13). These two indices are rou-
tinely available from the complete blood count 
(CBC) done by automated hematology analyz-
ers, without any additional cost. 
Based on the premise that a combination of 
two sensitive biomarkers can increase the di-
agnostic accuracy of each of them taken sepa-
rately, our aim was to assess the ratio of RDW 
to lymphocyte count (LY) in detecting CD pa-
tients – RDW/LY, who benefit from confirma-
tory tests. 
Material and methods
Study design and patients 
For this observational study, we consecu-
tively recruited newly diagnosed adult CD pa-
tients (CD-new) admitted to our clinic over a 
period of five years (2012-2017). Due to the 
frequent mislabeling as IBS, age-sex matched 
irritable bowel syndrome (IBS) patients were se-
lected as controls. We also included CD patients 
on gluten-free diet (CD-treated) who achieved 
seroconversion during the study period, serving 
as intra-group control. CD and IBS diagnoses 
were made based on currently available guide-
lines (3,14). We excluded from analysis patients 
with altered white blood cell (WBC) count and 
differential secondary to acute overt infections, 
systemic inflammatory states or hematologic 
malignancy and those with drug-induced WBC 
count changes. The study was approved by the 
local ethics committee. All patients signed an in-
formed consent.
Laboratory procedures
Routine hematological parameters were re-
corded for all patients as part of their routine 
clinical management. CBC was determined from 
venous blood samples using a Beckman Coulter 
Gen S hematology analyzer. A normal RDW was 
considered at values under 14, whereas the cut-
off value for normal lymphocyte count was 1.5 x 
10e9/L (1500/mm3). 
CD patients and controls were checked for 
serum CD autoantibodies, including IgA an-
ti-tissue transglutaminase 2 and anti-endomy-
sial antibodies. They also underwent upper GI 
endoscopy with multiple biopsies, both from the 
bulb and distal duodenum, using high-definition 
scopes (Pentax, Tokyo, Japan; and Olympus, To-
kyo, Japan). Duodenal lesions were reported ac-
cording to the Marsh-Oberhuber classification. 
We evaluated the differences in the afore-
mentioned hematologic indices and their ratio 
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among the three groups (CD-new, CD-treated, 
and IBS) and assessed the diagnostic accuracy 
of RDW/LY in detecting CD.
Statistical analysis
Data analysis was performed using SPSS 
Statistics version 20 (SPSS Inc., Chicago, IL) 
and Epi Info 7.1.5 (CDC, Atlanta, Georgia, 
USA). Results are expressed as mean ± standard 
deviation (SD) or proportion (%). Comparison 
of means between the groups was carried out us-
ing ANOVA. Diagnostic accuracy was assessed 
by sensitivity (Sn), specificity (Sp), positive pre-
dictive value (PPV), negative predictive value 
(NPV), positive and negative likelihood ratios. 
Receiver operating characteristic (ROC) curves 
were generated for ratios of hematologic indices 
and the area under the receiver operating char-
acteristic curve (AUROC) was used to compare 
the diagnostic performance of different ratios. 
Statistical significance was set at α=0.05.  
Results
Altogether 34 newly diagnosed CD patients 
and 34 IBS-controls were included in the anal-
ysis. Also, 16 GFD-treated CD patients served 
as intra-group control. All 34 controls had nega-
tive serum CD autoantibodies and were normal 
on duodenal biopsy. Of the 34 newly diagnosed 
CD patients, 70.59% were female, with a mean 
age of 40 ± 12 years. Of these, almost two thirds 
had anemia (64.70%). Mean RDW was highest 
in CD-new, and mean lymphocyte count was 
lowest in this group also (Table 1). An elevat-
ed RDW (>14) was seen in 79.41% of patients 
in the CD-new group, compared to 37.5% in 
CD-treated and 17.65% in the IBS group. Sim-
ilarly, lymphopenia (<1.5 x 10e9/L) was most 
prevalent in the CD group (38.24%), compared 
to 18.75% and 11.76% respectively, indicat-
ing some persisting low lymphocyte counts in 
GFD-treated CD patients.
Newly diagnosed CD patients had the high-
est RDW to lymphocyte ratio (RDW/LY), with a 
mean value of 10.09, compared to 7.72 and 6.79 
respectively (p<0.01) (Table 2). When analyzing 
its diagnostic performance, RDW/LY had a sen-
sitivity of 88.24% (95% CI 72.55-96.70%) and 
specificity of 68.00% (95% CI 53.30-80.48%) 
for a value over 7, with a PPV of 65.22% (95% 
CI 55.14-74.09%), NPV 89.47% (95% CI 76.85-
95.61%), positive likelihood ratio 2.76 (95% CI 
1.81-4.21), negative likelihood ratio 0.17 (95% 
CI 0.07-0.44) and an AUROC of 0.785 (95% CI 
0.683-0.887); its overall diagnostic accuracy was 
76.19% (95% CI 65.65%-84.81%) and diagnos-
tic odds ratio of 15.94 (95% CI 4.79-52.95).
Further analysis looking at the severity of 
histologic lesions in the CD-new group revealed 
that RDW/LY was higher in patients with de-
structive histology (Marsh≥3a, n=28), 10.54 ± 
Table 1. Mean RDW and lymphocyte count in the study groups
(mean ± SD) CD-new (n=34) CD-treated (n=16) IBS (n=34) P value
RDW 15.58 ± 2.51 14.11 ± 1.53 13.69 ± 1.38 0.0004
Lymphocyte count 1.760 ± 0.592 1.900 ± 0.441 2.211 ± 0.598 0.0059
Table 2. Hematologic indices ratios in the study groups
 CD-new (n=34) CD-treated (n=16) IBS (n=34) P value
RDW/LY 10.09 ± 6.02 7.72 ± 1.61 6.79 ± 2.64 0.007
NEU/LY 2.96 ± 3.19 2.01 ± 0.47 2.11 ± 0.73 0.16
PLT/LY 192.53 ± 86.72 144.47 ± 32.94 122.96 ± 41.55 <0.001
Bereitgestellt von  TAMPERE UNIVERSITY LIBRARY | Heruntergeladen  12.09.19 09:23   UTC
Revista Română de Medicină de Laborator Vol. 26, Nr. 1, Ianuarie, 201848
6.54 vs. 7.99 ± 1.32, but the difference did not 
reach statistical significance (p=0.09).     
Discussions
In the current study we evaluated chang-
es in hematologic indices, focusing on RDW, 
lymphocyte count and their ratio, in newly diag-
nosed and treated CD patients and IBS patients 
as controls.
As previously shown in the literature (15), 
our study revealed a significant reduction in 
peripheral lymphocyte counts in newly-diag-
nosed CD patients compared to controls and 
GFD-treated CD patients. Possible explanations 
for the low lymphocyte counts could be migra-
tion of lymphocytes in the intestinal mucosa, 
enteric loss and apoptosis of lymphocytes in the 
setting of the immune alterations of CD, and 
not least malnutrition (12,15,16). This has also 
been seen in other small bowel disorders such as 
protein-losing enteropathies, where fecal loss of 
lymphocytes and alterations in lymphocyte sub-
populations have been documented (17,18). In 
accordance with the findings of others (19) who 
reported lymphocyte counts returning to normal 
on GFD, we have also seen a significant increase 
in lymphocyte counts in GFD-treated patients; 
this is probably due to a decrease in lympho-
cyte leakage through the healed mucosa (Table 
1). However, mean lymphocyte counts in GFD 
treated CD patients do not reach the values of 
healthy controls; in fact, treated CD patients do 
not complete reverse the mucosal alterations as 
to a healthy person, and this has been reinforced 
by two studies reporting persistent duodenal in-
traepithelial lymphocytosis even in long-term 
strictly adherent patients (20,21).  
Regarding RDW, its value has been studied 
in various conditions, from cardiovascular dis-
ease to oncology (22,23). In our cohort, signifi-
cantly more patients in the newly diagnosed CD 
group had elevated RDW compared to the other 
two groups (79% vs. 37% and 17% respective-
ly). Our findings are consistent with those of pre-
vious studies, which also reported high rates of 
elevated RDW in newly diagnosed CD patients 
(53.7% and 67% respectively) (9,11,24). RDW 
is known to be an early indicator of iron defi-
ciency and altered erythropoiesis in CD patients. 
As shown in our study cohort, alterations 
in these two parameters (RDW and lymphocyte 
count) are frequent in newly diagnosed CD and 
they could be thought of as “hematologic diag-
nostic clues”, especially where a high index of 
suspicion exists. 
High statistical significance was achieved 
for the difference in the ratio of the two parame-
ters, RDW/LY, in the three groups (Table 2). In-
terestingly, in treated CD patients, the RDW/LY 
ratio decreased to values similar to those of IBS 
controls. This is an additional argument that al-
terations in the two parameters leading to a high 
ratio are due to gluten-intolerance. 
Other hematologic ratios (neutrophil-to-lym-
phocyte ratio NEU/LY, platelet-to-lymphocyte 
Table 3. Diagnostic performance of hematologic ratios for CD
 Sarikaya et al. 2014, 2015 (27,28) Our results
NEU/LY
Cut-off  2.32: Sn 80%, Sp 41%
AUROC 0.573
AUROC 0.607
PLT/LY
Cut-off 143.7: Sn 80.20%, Sp 53.90% 
AUROC 0.754
AUROC 0.708
RDW/LY Not reported previously
Cut-off 7: Sn 88.2%, Sp 68.0%
AUROC 0.785
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ratio PLT/LY) previously reported in the litera-
ture in various conditions such as bladder cancer 
or myocardial infarction (25,26), have also been 
studied in CD (27,28); they had good diagnostic 
performance in our cohort also, but RDW/LY ra-
tio proved to be better (Table 3). To the best of 
our knowledge, this is the first study to investi-
gate the diagnostic accuracy of RDW/LY ratio to 
diagnose CD. Changes in leukocytic formula in 
active CD leading to alterations in these hema-
tologic ratios may be related to the lymphocytic 
infiltration of the gastrointestinal tract, the in-
flammation and cytokines involved in the patho-
genesis of CD (28). 
The main limitation of the present study is 
the small sample size. If reproduced in larger 
studies, the ratio could have great implication for 
practice and serve as a valuable screening tool 
for CD. Screening using this ratio could be done 
even in primary care or ambulatory settings, 
where rapid hematology analyzers are available. 
Conclusion
Hematologic indices routinely measured by 
CBC may be useful in selecting patients with 
likelihood of CD, who benefit from further test-
ing. We report for the first time the good diag-
nostic performance of RDW/LY ratio for CD. 
This is a simple, widely available and cheap tool 
which could be used routinely in clinical prac-
tice for CD screening.   
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